<SEC-DOCUMENT>0001193125-26-241896.txt : 20260527
<SEC-HEADER>0001193125-26-241896.hdr.sgml : 20260527
<ACCEPTANCE-DATETIME>20260527160915
ACCESSION NUMBER:		0001193125-26-241896
CONFORMED SUBMISSION TYPE:	425
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20260527
DATE AS OF CHANGE:		20260527

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axalta Coating Systems Ltd.
		CENTRAL INDEX KEY:			0001616862
		STANDARD INDUSTRIAL CLASSIFICATION:	PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODUCTS [2851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				981073028
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		425
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36733
		FILM NUMBER:		261026223

	BUSINESS ADDRESS:	
		STREET 1:		1050 CONSTITUTION AVENUE
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19112
		BUSINESS PHONE:		(855) 629-2582

	MAIL ADDRESS:	
		STREET 1:		1050 CONSTITUTION AVENUE
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19112

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axalta Coating Systems Ltd.
		CENTRAL INDEX KEY:			0001616862
		STANDARD INDUSTRIAL CLASSIFICATION:	PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODUCTS [2851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				981073028
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		425

	BUSINESS ADDRESS:	
		STREET 1:		1050 CONSTITUTION AVENUE
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19112
		BUSINESS PHONE:		(855) 629-2582

	MAIL ADDRESS:	
		STREET 1:		1050 CONSTITUTION AVENUE
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19112
</SEC-HEADER>
<DOCUMENT>
<TYPE>425
<SEQUENCE>1
<FILENAME>d134130d425.htm
<DESCRIPTION>425
<TEXT>
<HTML><HEAD>
<TITLE>425</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Filed by Axalta Coating Systems Ltd.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pursuant to Rule 425 under the Securities Act of 1933, as amended</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>and deemed filed pursuant to Rule 14a-12 of the</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Securities Exchange Act of 1934, as amended</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subject
Company: Axalta Coating Systems Ltd.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(Commission File No.: 001-36733)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Date: May 27, 2026</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following Employee Letter is being filed in connection with the proposed merger of equals transaction between Axalta
Coating Systems Ltd. and Akzo Nobel N.V.: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g134130dsp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;27, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Team,
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I wanted to let everybody know that this week Axalta and AkzoNobel plan to publicly file a combined registration statement/proxy statement (Form <FONT
STYLE="white-space:nowrap">F-4)</FONT> with the U.S. Securities and Exchange Commission (SEC) related to our proposed merger of equals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This filing is a
normal step in the shareholder approval process. It provides significant detail about the merger of equals as required by the SEC, including additional information about the transaction structure, risk considerations, strategic rationale, combined
company governance and expected value creation. The public filing of the Form <FONT STYLE="white-space:nowrap">F-4</FONT> will allow us to proceed with shareholder votes in the back half of July. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may have also seen that AkzoNobel issued a press release today regarding unsolicited bids to break up their company. As the release makes clear, the
AkzoNobel boards rejected the bids and reaffirmed their commitment to our merger of equals. We continue to believe this combination will create a premier global coatings company that will allow us to accelerate our growth ambitions and create
significant long-term value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Importantly, there are no changes to your role, responsibilities or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> work as a result of this filing, and I encourage you to continue focusing on the strong momentum and execution underway across the business. Axalta continues to operate from a position of strength,
supported by strong financial performance and a clear long-term standalone strategy. Axalta and AkzoNobel will continue operating as separate companies until the transaction closes, which is expected to occur in late 2026 to early 2027, subject to
shareholder and regulatory approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may see additional media coverage or external commentary in the coming days in connection with this filing,
which may naturally result in additional questions. Should you have any questions or receive any inquiries from external stakeholders regarding this latest development, please reach out to your manager or send an email to <U>info@axalta.com</U>. We
will continue to share updates as we are able. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I want to thank the many teams across Axalta who contributed significant time and effort to support this
important milestone in the process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I also want to express how grateful and proud I am of the progress we have made together as ONE Axalta. I am
confident the best is yet to come and look forward to continuing this journey together. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Best, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chris </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g134130dsp1a.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, any jurisdiction in which such
release, publication, or distribution would be unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is not a prospectus and the information in this communication is not intended
to be complete. This communication is for informational purposes only and is not intended to be and shall not constitute a solicitation of any vote or approval, or an offer to buy or sell, or the solicitation of an offer to buy or sell, any
securities, or an invitation or recommendation to subscribe for, acquire or buy securities of AkzoNobel or Axalta or any other financial products or securities, in any place or jurisdiction, nor shall there be any offer, solicitation or sale of
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a
prospectus meeting the requirements of Section&nbsp;10 of the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any decision to
purchase, subscribe for, otherwise acquire, sell or otherwise dispose of any securities must be made only on the basis of the information contained in and incorporated by reference into the prospectus with respect to the shares to be allotted by
AkzoNobel in the proposed transaction once published. A prospectus in relation to the proposed transaction described in this communication is expected to be published in due course. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The distribution of this communication may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this
document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, AkzoNobel and Axalta disclaim any responsibility or liability for the violation of any such restrictions by any person. Neither
AkzoNobel, nor Axalta, nor any of their advisors assume any responsibility for any violation by any person of any of these restrictions. Shareholders of AkzoNobel and Axalta, respectively, with any doubt as to their position should consult an
appropriate professional advisor without delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is addressed to and directed only at, persons who are outside the United Kingdom or,
in the United Kingdom, at persons who are: (i)&nbsp;persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the
&#8220;Order&#8221;), (ii) persons falling within Article 49(2)(a) to (d)&nbsp;of the Order, or (iii)&nbsp;persons to whom it may otherwise lawfully be communicated pursuant to the Order (all such persons together being referred to as,
&#8220;Relevant Persons&#8221;). This communication is directed only at Relevant Persons. Other persons should not act or rely on this communication or any of its contents. Any investment or investment activity to which this communication relates is
available only to Relevant Persons and will be engaged in only with such persons. Solicitations resulting from this communication will only be responded to if the person concerned is a Relevant Person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
connection with the proposed transaction between AkzoNobel and Axalta, AkzoNobel will file with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) a registration statement on Form <FONT STYLE="white-space:nowrap">F-4,</FONT> which
will include a proxy statement of Axalta that also constitutes a prospectus with respect to the shares to be offered by AkzoNobel in the proposed transaction. The definitive proxy statement/prospectus will be sent to the shareholders of Axalta. Each
of AkzoNobel and Axalta will also file other relevant documents in connection with the proposed transaction. This communication is not a substitute for any registration statement, proxy statement/prospectus or other documents AkzoNobel and/or Axalta
may file with the SEC or any other </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
competent regulator in connection with the proposed transaction. This communication does not contain all the information that should be considered concerning the proposed transaction and is not
intended to form the basis of any investment decision or any other decision in respect of the proposed transaction. <B>BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS, INVESTORS, STOCKHOLDERS AND SHAREHOLDERS OF AKZONOBEL AND AXALTA ARE URGED TO
READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE
PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT AKZONOBEL, AXALTA, THE PROPOSED TRANSACTION AND RELATED MATTERS.</B> The registration statement and proxy statement/prospectus and other
relevant documents filed by AkzoNobel and Axalta with the SEC, when filed, will be available free of charge at the SEC&#8217;s website at www.sec.gov. In addition, investors and shareholders will be able to obtain free copies of the proxy
statement/prospectus and other documents filed with the SEC from Axalta&#8217;s investor relations webpage at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">https://ir.axalta.com/sec-filings/all-sec-filings</FONT></FONT></FONT> or from AkzoNobel&#8217;s investor relations webpage at
https://www.akzonobel.com/en/investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The contents of this communication should not be construed as financial, legal, business, investment, tax or
other professional advice. Each recipient should consult with its own professional advisors for any such matter and advice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the
Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is not a solicitation of proxies in connection with the proposed transaction. However, under SEC rules, AkzoNobel,
Axalta and certain of their respective directors and executive officers and other members of their respective management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction.
Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests in the proposed
transaction, by security holdings or otherwise, will be set forth in the proxy statement/prospectus and other relevant materials when it is filed with the SEC. Information regarding the directors and executive officers of Axalta is contained in
Axalta&#8217;s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC April&nbsp;21, 2026, its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2025, which was
filed with the SEC on February&nbsp;13, 2026, subsequent statements of beneficial ownership on file with the SEC, including the Initial Statements of Beneficial Ownership on Form 3, Statements of Change in Ownership on Form 4 or Annual Statements of
Beneficial Ownership on Form 5 filed with the SEC on: 3/3/2026 and 3/5/2026, and other filings made from time to time with the SEC. Information about AkzoNobel&#8217;s supervisory board members and members of the board of management is set forth in
AkzoNobel&#8217;s latest annual report, as filed with the AFM, the Dutch trader register and on its website at <U>https://www.akzonobel.com/en/investors/results-center</U>, and as updated from time to time via filings made by AkzoNobel with the AFM.
Additional information regarding the interests of persons who may, under the rules of the SEC, be deemed participants in the solicitation of Axalta security holders in connection with the proposed transaction, which may, in some cases, be different
than those of Axalta&#8217;s shareholders generally, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement/prospectus and other relevant materials when they are
filed with the SEC. These documents can be obtained free of charge from the sources indicated above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Concerning Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains forward-looking statements as that term is defined in Section&nbsp;27A of the Securities Act, and Section&nbsp;21E of the
Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995, regarding, among other things, statements about management&#8217;s expectations of AkzoNobel&#8217;s and Axalta&#8217;s future operating and
financial performance, product development, market position, and business strategy. Such forward-looking statements can sometimes be identified by the use of forward-looking terms such as &#8220;believes,&#8221; &#8220;expects,&#8221;
&#8220;may,&#8221; &#8220;will,&#8221; &#8220;shall,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;seeks,&#8221; &#8220;aims,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;is
optimistic,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; &#8220;targets,&#8221; &#8220;anticipates,&#8221; &#8220;continues&#8221; or other comparable terms or negatives of these terms, but not all forward-looking
statements include such identifying words. You are cautioned not to rely on these forward-looking statements. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and
assumptions.&nbsp;Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.&nbsp;We
can give no assurance that such plans, estimates or expectations will be achieved and therefore, actual results may differ materially from any plans, estimates or expectations in such forward-looking statements.&nbsp;Important factors that could
cause actual results to differ materially from such plans, estimates or expectations include: a condition to the closing of the proposed transaction may not be satisfied; the occurrence of any event that can give rise to termination of the proposed
transaction; a regulatory approval that may be required for the proposed transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated; AkzoNobel and Axalta are unable to achieve the synergies and value
creation contemplated by the proposed transaction; AkzoNobel and Axalta are unable to promptly and effectively integrate their businesses; management&#8217;s time and attention is diverted on transaction related issues; the possibility that
competing offers or acquisition proposals may be made; disruption from the proposed transaction makes it more difficult to maintain business, contractual and operational relationships; the credit ratings of AkzoNobel or Axalta decline following the
proposed transaction; legal proceedings are instituted against AkzoNobel or Axalta, including resulting expense or delay; AkzoNobel or Axalta is unable to retain or hire key personnel; the communication or the consummation of the proposed
acquisition has a negative effect on the market price of the capital stock of AkzoNobel or Axalta or on AkzoNobel&#8217;s or Axalta&#8217;s operating results; evolving legal, regulatory and tax regimes; changes in economic, financial, political and
regulatory conditions, in the Netherlands, the United States and elsewhere, and other factors that contribute to uncertainty and volatility, natural and <FONT STYLE="white-space:nowrap">man-made</FONT> disasters, civil unrest, pandemics (e.g., the
coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> pandemic), geopolitical uncertainty, and conditions that may result from legislative, regulatory, trade and policy changes associated with the current or subsequent United States or
Netherlands administration; the ability of AkzoNobel or Axalta to successfully recover from a disaster or other business continuity problem due to a hurricane, flood, earthquake, terrorist attack, war, pandemic, security breach, cyber-attack, power
loss, telecommunications failure or other natural or <FONT STYLE="white-space:nowrap">man-made</FONT> event, including the ability to function remotely during long-term disruptions; the impact of public health crises, such as pandemics and epidemics
and any related company or governmental policies and actions to protect the health and safety of individuals or governmental policies or actions to maintain the functioning of national or global economies and markets, including any quarantine,
&#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; workforce reduction, social distancing, shut down or similar actions and policies; actions by third parties, including government agencies; the risk that disruptions from the proposed
transaction will harm AkzoNobel&#8217;s or Axalta&#8217;s business, including current plans and operations and/or divert management&#8217;s attention from AkzoNobel&#8217;s or Axalta&#8217;s ongoing business operations; certain restrictions during
the pendency of the acquisition that may impact AkzoNobel&#8217;s or Axalta&#8217;s ability to pursue certain business opportunities or strategic transactions; AkzoNobel&#8217;s or Axalta&#8217;s ability to meet expectations regarding the accounting
and tax treatments of the proposed transaction; the risks and uncertainties discussed in AkzoNobel&#8217;s latest annual report as filed with the AFM, the Dutch trader register and on its website at
<U>https://www.akzonobel.com/en/investors/results-center</U>; and the risks and uncertainties discussed in the &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
sections in Axalta&#8217;s reports filed with the SEC. These risks, as well as other risks associated with the proposed transaction, will be more fully discussed in the proxy statement/prospectus. Unlisted factors may present significant additional
obstacles to the realization of forward-looking statements. We caution you not to place undue reliance on any of these forward-looking statements as they are not guarantees </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of future performance or outcomes and that actual performance and outcomes, including, without limitation, our actual results of operations, financial condition and liquidity, and the development
of new markets or market segments in which we operate, may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Except as required by law, neither AkzoNobel nor Axalta assumes any
obligation to update or revise the information contained herein, which speaks only as of the date hereof. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g134130dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g134130dsp1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "; JT# 1$  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H RI[V9)G4/@!B!P*JP#/M\_\ ST_046 /M\__ #T_046
M/M\__/3]!18 ^WS_ //3]!18 ^WS_P#/3]!18 ^WS_\ /3]!18 ^WS_\]/T%
M%@#[?/\ \]/T%%@#[?/_ ,]/T%%@#[?/_P ]/T%%@#[?/_ST_046 /M\_P#S
MT_046 /M\_\ ST_046 /M\__ #T_046 /M\__/3]!18 ^WS_ //3]!18 ^WS
M_P#/3]!18 ^WS_\ /3]!18 ^WS_\]/T%%@#[?/\ \]/T%%@#[?/_ ,]/T%%@
M#[?/_P ]/T%%@#[?/_ST_046 /M\_P#ST_046 /M\_\ ST_046 /M\__ #T_
M046 /M\__/3]!18 ^WS_ //3]!18 ^WS_P#/3]!18 ^WS_\ /3]!18 ^WS_\
M]/T%%@#[?/\ \]/T%%@#[?/_ ,]/T%%@#[?/_P ]/T%%@#[?/_ST_046 /M\
M_P#ST_046 /M\_\ ST_046 /M\__ #T_046 /M\__/3]!18 ^WS_ //3]!18
M ^WS_P#/3]!18 ^WS_\ /3]!18 ^WS_\]/T%%@#[?/\ \]/T%%@#[?/_ ,]/
MT%%@#[?/_P ]/T%%@#[?/_ST_046 /M\_P#ST_046 /M\_\ ST_046 /M\__
M #T_046 /M\__/3]!18 ^WS_ //3]!18 ^WS_P#/3]!18 ^WS_\ /3]!18 ^
MWS_\]/T%%@#[?/\ \]/T%%@#[?/_ ,]/T%%@,CQ7XR_X1;19[Z>49081,#+-
MV%>-FN8T\LPLJ\^FWFST<!@YX[$1HP6_7R/%_B)\>M?^&GPWDU74-05]>U0D
M:;:&&,"%?[Y 7G'OFNO@O!9CF_[[,)>ZW=*R5E\DF>=Q;C\%E:]G@E:2TO=N
M[^=SYC;]L3XO@_\ (W8_[AEG_P#&:_</]7\M_P"?7XR_S/QW_6#,G_R]_"/^
M1$W[8_QA'_,W_P#E,L__ (S1_J_EG_/K_P FE_F'^L&9?\_?PC_D1M^V5\80
M,_\ "8?^4RS_ /C-'^K^6_\ /K_R:7^8?V_F7_/W\(_Y#3^V7\8L_P#(X?\
ME,L__C-'^K^6_P#/K_R:7^9I_;V8_P#/W\(_Y$9_;.^,8_YG'_RF6?\ \9H_
MU?RW_GU^,O\ ,K^W<Q_Y^_A'_(8W[9_QD!_Y''_REV?_ ,9I/A_+?^?7XR_S
M+6>YA_S\_"/^1&?VTOC+_P!#C_Y2[+_XS4_V!EO_ #Z_&7^9NL[Q_P#S\_"/
M^0QOVU/C..GC+_REV7_QFC^P,M_Y]?C+_,O^V<?_ ,_/PC_D0/\ ML?&@=/&
M?_E+LO\ XS5_ZOY;_P ^O_)I?YC_ +9QW_/S\(_Y$+_MN?&M<X\:?^4JR_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M84!9A0%F% 684!9A0%F% 684!9A0%F% 684!9A0%F% 684!9A0%F'6C05F%
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M9M1_[_5T_P!FX3_GVCG_ +4QG_/Q@/C)XV_Z&;4?^_U-9;A+_P -"_M3&?\
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MP\<-1C2CT/P_$UY8FM*M+J8\:&214499B !ZUU-\JYCG2YG8^X8],TT>#%\
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MM&L4: = !BOQ>I4=6;G+=G[53IQI04([(N5!J% !0 4 % !0 4 % !0 4 %
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MF#%IXD^MM_[5KY_,U[T?G^AZ.'^$_7NOS,]HP[K_ (^)?]XU0$=, % 'S_\
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MCC'10:^+SK,UCJJC3?NH^XR3+'@:3E57O,]LKYL^F"@ H * "@ H * "@ H
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M"@+(* L@H"R"@+(* L@H"R"@+(* L@H"R"@+!0,* "@ H * "@ H * "@ H
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M:P)"'/5MJ@9_2F!\X?\ !1OX??\ "?\ [*'BU8X?.NM+5-2B &3F,\X_ T6
M^'?^"-_CT:/\7O%/A>63":MIXGB3/!>-LG]#4@</_P %6O&[>,/VI)M(BD\V
M'1;**T1 <[7;YF'YXI@?6_QL^'Z_#+_@EE#H039-'IEM--QC+NP<G]12 \'_
M ."0W_'Q\8_^P"/YM5(#Q']@W_D^+PI_V%)__9J3 I?M5_\ )^'B;_L9X/\
MT..D!^I?[5W[%>@_M56_A74-<\3W'AV+1K0QYB1"KAL')+=*=@/@S]JK]@'P
M#\$/A/?>*O#'Q(37M2L94633I982SJQP2H0YR*0'HG_!,#5M0^+7P9^+?PMU
M6:2\TDV)>TBD;<(C(I7:N>@W &@#Y_\ V /$EQ\(_P!M/1-+NG,(FN;C1KA7
MXR3E>?Q6@#Z%_P""SWC\2ZOX$\'1/GR8Y=0F4'H3\JY_"G<#U;]E']DFU^('
M[ 47A'5+R71I?%DIU*:[A0%U7=\@P?84@/-_$7_!*+X7:)I=\#\6VAU.*)VC
MCN'MU&\ D C=GK0!\U?\$]/'.L?#3]KK0=#L;YGL=1O)-+NXT;]W.HW -CIU
M7(- &1^W_:M??MI>-[9&"/-?QQJQ[$A1G]: /T!_9&_X)K:9\$O%?ASXAWOB
MVYU37(8/.^RQ0A8,R(.,GGC-.P',?$+_ ()3_#S4_%NKZ[KOQ+NM*?4KN2[,
M4HAC"EV+8!8C.,T@/@;]ISX06?[+'QI@T[PAXL&NP0117UIJ=O(N]&ZX)0XR
M"* /J;_@HSX9NOB/^SC\&_BW,A>_:QCM+^3'7>N58GW8&@#WO_@E5\5X]0_9
M<U:QNY03X6N9BV3TB*^8/Y&J0'YV?#;1[G]I7]M.T24F9=8\1-=3.>0(5D+9
M/MA0*D#]/?VKO^"?GA7]HGQO9^*]:\7W/AJ"SL8[$0QI'Y85.AW,>*H#X%_;
M)_8F\%_L[^!;#Q'X2\?Q^)W>Z%M<6;R1,Z@CAAL)J0/:_P!E[XCZOXT_X)N_
M&+2=4N9+M-!@>WM9)6+,L;J&VY/8=J /DC]C#]F3_AJCXE7'A>76SHEE;VQN
M[B5$WNZ@XPHZ9^M &Y^W'^R=:?LB>.] TW2M;N-7M-4LVNXIIT"21LK[2./?
MF@#]>_V)?&-]X[_9<\ :MJ4K7%Z^GK')*YRSE"5!/X 50'N-, H * "@ H *
M "@ H * .4^*7Q%TSX5^"=2\1:G(%AM8R43/,DG\*CW)KKPF&GBZRHP.7$5X
MX>FZDCX_\%:G=>$="UOXW>,5\SQ7X@+0Z%:2]88ST8 ] !7VM2"Q$X9=0^"/
MQ/NSY2IB%AJ;QM7XI;+L?/\ J6IW.LZA<7UY*T]U<.9))&/+,>37VU&FJ,%3
MCLC\[J3=63G+=D:GM6QBR0-Q3)L*#@^U!(Z@ H * &L.*N($9'%4!$0"#09%
MO0V,6J1-L\S'.S^][5\7Q9%2RJ=UL?><&3<,XAKN<CXT,4GCZTF2-HOWH9AC
M !K^=Z:?L)'])UG?$1L?6OPHUN+[!%OF&#@]:^>DG<]ZI;ET.G\8^.[2".:.
M&Y2*.)"6 ;ECZ5Z<(-[H\WFBMV?+$_[4-QX1U](;G2G>QCFR]RI#;AFNCZE[
M6-U+4RGC%2=FM#T;Q9^VQ;ZC9POHFCM?3J@*L5V #WJYX*<[<SV,(XBG35UU
M&^ _BK<>+(;B[U2%-/OR 8DADSL]#6;H>S7+%W.J.(A+<]BT/XEPZYH#+.Z&
MX3Y)"#W]:\_$4Y),Z*2BYW1\X_'BY&IQ,(6!82!D(]<U6 5IILK').F=8)'T
M[X)W%W>7 CN8X/+2(G&\D8S7TV08>6)S>G%*Z3N?.9]B%A\JJ2;M=6/FAQFO
MZJ2LK'\PMW=RM,OI3&0,,B@N+(&%!LMB,BDTC6+$;FL3JB1FLV:C&J&=$7<:
MR]JAFZT(FYK-FB>A]$_LH?\ 'IXCX[V__M6OG<S^*/S_ $/2PS]UGZZU^8GT
M9AW7_'Q+_O&J CI@% 'SQ^W]X,N_'/[*/CBQL8VFN8;<7:QH,EO+.3^F:E@?
MF1_P3 ^.'A[X+?'2]A\47T>EZ;K=E]D%Y,<1QR!MR[CV!Z9I ?L$_P >OAS$
M8]WC?0LR$! +Z,EB>G>J _(K_@K9*DW[5(DC8.CZ-:,K Y!!4X-0!^GWP\_Y
M,QT__L3Y/_29J?0#\G/^"7G_ ">#X:_Z]KG_ - H YKXN_\ )^6K?]CC%_Z.
M2@#]UOB7_P DY\4_]@NZ_P#1350'XF_\$U?^3S/#?_;S_P"@U('Z/_M1_LB_
M!W]IV:ZO6US3-#\:(#'_ &E:74>YF'19DS\W\Z; _+.ZU'QU^PI\>Y;#2/$D
M<]UITJ/(^G3[[:[B/.UE!QR.QY%(#]Z/ WB$^+?!FAZVT?E/J%E#=-'_ '2Z
M!B/UJD [QKX>C\6>#];T650\>H6<ML0W3YD('\Z8'X2_LJ>)?^&??VR]%_M2
M46=K8ZK-IUX\AVA8R64D_D*@"M(LO[17[<3!#]J77/$_4<@Q+)_+:E,#]6?^
M"C5I'8?L:>+K:)0D4,4$:*.RA@ /TH8'Q;_P2&_X^/C'_P!@$?S:F@/$?V#?
M^3XO"G_84G_]FI,"G^U7_P GX>)O^QG@_P#0XZ0'MW_!4SX\^+1\4].\ 6.K
M76F^'['3+>=H+60QB>1UR6<CKCI0!3^+G[!?A?X;?LI?\+*G\<W>I^();*"Z
M6T\Q/)=I,$J.<G&: .W_ ."+'_(S?$C_ *]+?_T,TT!X;^V?X5E^ G[<USK%
MLIM;274;?6H&3@;68%L?D?SI 4_VR?&B_M,_M?6L&CS+>6ER;+3;=H6W*<A=
MQ'_?1_*@#[M_X*)?$77/V:_V6?"GAOP?=2:3+>-'I37=L=KQQ1Q M@]MWK5,
M#Y/_ &.?V+-'_:<^&NL>.?&/CZ_L'@N)(5@CG#.-HR6D9SQFI \?_8]TV#1O
MVVO!=A;2F>WM=>>&.4G)=5+@'\0* -/]NS_D^7Q7_P!A:#_V6@#]L-2U^7PK
M\&Y]9@0/-I^A_:44]V2#</U%4@/Q-^"6D^(/VY?VC!I/C/QI?6*:@)KJ6=IB
M=BKR(XU)VCT%2!F?MQ_L^^'_ -G#XGV?AKP]KEQKUO)9+/+-<NK.CD_=^4\4
M ?IEKWPQ7XL_\$V-/T181-=IX:CN[88Y$L8W C\ : /S5_98_:#_ .%*?#_X
MOZ)-=&UGUS13#91GC-QNVG\=I(H ]X_X(\_#$:[\6?$GC2X@+P:-9_9X)&''
MFR'G\=HH XO_ (*$?&WQA\1/VI]4\"'7+K3/#^F7T>FP6L<QCB!.T&1L$9^]
MW]* -+]L+]AGPK^SM\"]-\4V?C2[U[7+F>&-K>9T\M@XRS* <D#UH W_ -B_
M_E'_ /M$?A_Z*% &7_P1T_Y.#U__ + S?^A4T!T__!:?_DI/PY_[!-Q_Z.%
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MCM0 M !0 4 % "$@'&X9],TK@+3 * #H"2< >M "9R,YXH 7K0 4 % !0 4
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MQ#-9WW@]IA!=O;K()TE)\Q64\#(. 1TH ]C ( !.3W/K3 6@ H * "@ H *
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M_0]C"/W6?K=7Y6?5&'=?\?$O^\:H".F 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M["8>-HP5S#8SW3EI)'D8]V8DUARREJV=EU'9#)(2@QCDTN2UD5S7+2:>N$W
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@!&(4$DX
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M 'V&7^Z: #[#+_=- !]AE_NF@ ^PR_W30 ?89?[IH /L,O\ =- !]AE_NF@
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MCR23W_0]/"X2I33YD?HI7YX?2A0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
C0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g134130dsp1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g134130dsp1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  1 JH# 1$  A$! Q$!_\0
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M3'[G_F'_  \L\/\ _0E:G_X&1_X4?VM#^1A_Q#;$_P#03'[G_F'_  \L\/\
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M^'HGAS_H1M4_\#(__B:?^J57_GZON8O[=I_R/[P_X>B>'/\ H1M4_P# R/\
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M4JO_ #]7W,/[=I_R/[P_X>B>'/\ H1M4_P# R/\ ^)H_U2J_\_5]S#^W:?\
M(_O#_AZ)X<_Z$;5/_ R/_P")H_U2J_\ /U?<P_MVG_(_O#_AZ)X<_P"A&U3_
M ,#(_P#XFC_5*K_S]7W,/[=I_P C^\/^'HGAS_H1M4_\#(__ (FC_5*K_P _
M5]S#^W:?\C^\/^'HGAS_ *$;5/\ P,C_ /B:/]4JO_/U?<P_MVG_ "/[P_X>
MB>'/^A&U3_P,C_\ B:/]4JO_ #]7W,/[=I_R/[P_X>B>'/\ H1M4_P# R/\
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M_+_A1_Q$3#?] \OO0?ZF5O\ G\ON8?\ #3>F_P#0$NO^_P O^%'_ !$3#?\
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M_@P_U_PG_/I_^!1_S#_AWYXF_P"A@A_\%ES_ /$T?V94[_@P_P!?\)_SZ?\
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MKWA/^?3_ / HA_PR)K7_ $%X_P#P"F_PH_U6K_S_ (,/]>\)_P ^G_X%$/\
MAD36O^@O'_X!3?X4?ZK5_P"?\&'^O>$_Y]/_ ,"B03_L?ZW*"!K$8_[<9O\
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M_8U3^;\&'_#N?Q1_T,</_@KN?_B:/]9J'\GXH/[&J?S?@P_X=S^*/^ACA_\
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M_P!;,/\ \^W_ .!1#_AGC4_^@BG_ ("R?X4?ZBXO_GZO_ 9!_K9A_P#GV_\
MP*(?\,\:G_T$4_\  63_  H_U%Q?_/U?^ R#_6S#_P#/M_\ @40_X9XU/_H(
MI_X"R?X4?ZBXO_GZO_ 9!_K9A_\ GV__  *(?\,\:G_T$4_\!9/\*/\ 47%_
M\_5_X#(/];,/_P ^W_X%$/\ AGC4_P#H(I_X"R?X4?ZBXO\ Y^K_ ,!D'^MF
M'_Y]O_P*(?\ #/&I_P#013_P%D_PH_U%Q?\ S]7_ (#(/];,/_S[?_@40_X9
MXU/_ *"*?^ LG^%'^HN+_P"?J_\  9!_K9A_^?;_ / HA_PSQJ?_ $$4_P#
M63_"C_47%_\ /U?^ R#_ %LP_P#S[?\ X%$/^&>-3_Z"*?\ @+)_A1_J+B_^
M?J_\!D'^MF'_ .?;_P# HGT98PFVLK>(G)CC5"?H,5^]T8.G2C!]$D?D=67/
M4E)=6R>MC(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
8"@ H * "@ H * "@ H * "@ H * /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
